December 22, 2016
Allergan/Ironwood’s enhanced linaclotide CR1 could double Linzess franchise from $1B in U.S. net sales by 2020
Ironwood Pharmaceuticals and Allergan have been testing an irritable bowel syndrome with constipation (IBS-C) drug, a formulation of linaclotide colonic…